Journal
RESEARCH IN NURSING & HEALTH
Volume 29, Issue 2, Pages 87-97Publisher
WILEY
DOI: 10.1002/nur.20114
Keywords
mice; cachexia; B16 melanoma; Lewis lung carcinoma; tumor necrosis factor-alpha; indomethacin; cyclooxygenase
Categories
Funding
- Intramural NIH HHS Funding Source: Medline
Ask authors/readers for more resources
Tumor-induced skeletal muscle wasting (SMW) contributes to the fatigue and weakness experienced by persons with cancer cachexia. Tumor necrosis factor-alpha (TNFa) and cyclooxygenase (COX) activity have been implicated in SMW in some animal models of cancer cachexia. We report that indomethacin, a nonspecific inhibitor of COX, and NS398, a specific inhibitor of COX2, preserved muscle mass and reduced type 1 TNF receptors in muscles of mice bearing the Lewis lung carcinoma, but not in mice bearing the B16 melanoma. These data suggest that tumor-induced SMW can occur via a COX2-independent pathway. The COX2-dependent pathway may involve reducing the catabolic effects of TNFa in muscle. Further study is needed to understand the relationship between COX and SMW, and whether patients with cancer cachexia might benefit from COX inhibitors. (c) 2006 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available